Durham, United States
Tiamat Sciences Corp., founded in 2019, is a promising player in the Biotechnology sector, with notable intersections in Food and Beverage and AgriTech. Headquartered in the United States, Tiamat Sciences is spearheading a plant-based approach to produce innovative reagents, crucial for the pharmaceutical industry.
By leveraging this unique platform, Tiamat aims to empower partners to develop advanced therapies, while simultaneously reducing costs, accelerating development, and advancing decarbonization efforts. Their slogan, "Empowering the Biotech Revolution - Providing Innovative Reagents for the Next Generation of Pharmaceutical Products", encapsulates their mission succinctly.
In its most recent financial activity, Tiamat secured a $2.00M seed round investment on 09 March 2023. Key investors include True Ventures, Social Impact Capital, Exponential Impact, and others, showcasing broad interest and confidence in their innovative model.
